In addition to its role in inflammation, MIF has been validated as a therapeutic target in numerous cancers, including (but not limited to)

• Colon cancer
• Prostate cancer
• Ovarian cancer
• Gastric cancer
• Breast cancer

In the case of colon cancer, a potential role in cancer prevention in patients with extensive colitis is suggested by the dual contribution of MIF to colitis and colon cancer.